PhiChem Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	3,398	3,226	2,899	2,713	2,863	2,607
Other Revenue	-	-	18.51	15.61	43.34	20.32
Revenue	3,398	3,226	2,918	2,729	2,907	2,627
Revenue Growth (YoY)	15.19%	10.56%	6.92%	-6.13%	10.65%	40.94%
Cost of Revenue	2,123	2,051	1,913	1,792	1,765	1,582
Gross Profit	1,274	1,174	1,005	936.4	1,142	1,045
Selling, General & Admin	479.99	466.11	433.18	438.35	395.77	337.22
Research & Development	213.27	208.59	181.65	189.24	183.69	192.74
Other Operating Expenses	5.54	2.93	10.89	7.3	20.19	23.35
Operating Expenses	698.8	677.63	657.5	655.06	601.71	561.37
Operating Income	575.61	496.84	347.36	281.34	540.27	483.54
Interest Expense	-	-	-44.83	-56.31	-59.06	-66.63
Interest & Investment Income	7.84	64.07	57.48	57.17	22.05	89.17
Currency Exchange Gain (Loss)	-	-	3.47	2.81	13.02	-3.49
Other Non Operating Income (Expenses)	-29.32	-30.55	-9.88	-159.95	-8.9	-11.13
EBT Excluding Unusual Items	554.13	530.36	353.6	125.06	507.38	491.45
Impairment of Goodwill	-	-	-	-	-1.48	-1.55
Gain (Loss) on Sale of Investments	-18.5	-16.91	-53.05	5.26	-26.78	-32.93
Gain (Loss) on Sale of Assets	-21.43	-15.38	-1.51	0	0.13	-1.05
Asset Writedown	-39.81	-27.88	-12.55	-1	-1.57	-2.66
Other Unusual Items	-	-	18.43	21.93	15.42	21.16
Pretax Income	474.39	470.19	304.93	151.24	493.11	474.41
Income Tax Expense	51.44	62.74	32.56	15.43	49.57	73.45
Earnings From Continuing Operations	422.96	407.45	272.37	135.81	443.54	400.96
Minority Interest in Earnings	-21.1	-17.05	-25.84	-23.46	-8.97	-15.1
Net Income	401.86	390.4	246.53	112.35	434.57	385.87
Net Income to Common	401.86	390.4	246.53	112.35	434.57	385.87
Net Income Growth	31.14%	58.36%	119.42%	-74.15%	12.62%	67.89%
Shares Outstanding (Basic)	562	550	525	535	517	514
Shares Outstanding (Diluted)	562	550	525	535	517	514
Shares Change (YoY)	8.41%	4.83%	-1.96%	3.42%	0.56%	0.73%
EPS (Basic)	0.71	0.71	0.47	0.21	0.84	0.75
EPS (Diluted)	0.71	0.71	0.47	0.21	0.84	0.75
EPS Growth	20.97%	51.06%	123.81%	-75.00%	12.00%	66.67%
Free Cash Flow	350.14	175.28	413.89	19.06	202.31	-10.85
Free Cash Flow Per Share	0.62	0.32	0.79	0.04	0.39	-0.02
Dividend Per Share	-	-	0.095	0.080	0.080	0.070
Dividend Growth	-	-	18.75%	-	14.29%	7.69%
Gross Margin	37.51%	36.41%	34.44%	34.32%	39.29%	39.77%
Operating Margin	16.94%	15.40%	11.91%	10.31%	18.59%	18.41%
Profit Margin	11.83%	12.10%	8.45%	4.12%	14.95%	14.69%
Free Cash Flow Margin	10.30%	5.43%	14.19%	0.70%	6.96%	-0.41%
EBITDA	810.29	721.44	531.66	458.88	685.88	604.68
EBITDA Margin	23.85%	22.37%	18.22%	16.82%	23.59%	23.02%
D&A For EBITDA	234.68	224.6	184.3	177.54	145.61	121.14
EBIT	575.61	496.84	347.36	281.34	540.27	483.54
EBIT Margin	16.94%	15.40%	11.91%	10.31%	18.59%	18.41%
Effective Tax Rate	10.84%	13.34%	10.68%	10.20%	10.05%	15.48%
Revenue as Reported	-	-	2,918	2,729	2,907	2,627
Advertising Expenses	-	-	1.26	7.13	1.24	3.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.